66 related articles for article (PubMed ID: 8588365)
1. [Inhibition of histamine liberation in allergic rhinoconjunctivitis in relation to the season].
Räderer I; Haen E; Schudt C; Przybilla B
Wien Med Wochenschr; 1995; 145(17-18):456-8. PubMed ID: 8588365
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of IgE-mediated histamine release from human peripheral leukocytes by selective phosphodiesterase inhibitors.
Kleine-Tebbe J; Wicht L; Gagné H; Friese A; Schunack W; Schudt C; Kunkel G
Agents Actions; 1992 Jul; 36(3-4):200-6. PubMed ID: 1382373
[TBL] [Abstract][Full Text] [Related]
3. Some alterations of the leucocyte beta2-adrenoceptor/cAMP-system in patients with seasonal allergic rhinoconjunctivitis are related to disease activity.
Haen E; Bleise U; Przybilla B
Clin Exp Allergy; 1997 Jul; 27(7):787-95. PubMed ID: 9249271
[TBL] [Abstract][Full Text] [Related]
4. Comparison of nasal immunohistology in patients with seasonal rhinoconjunctivitis treated with topical steroids or specific allergen immunotherapy.
Rak S; Heinrich C; Scheynius A
Allergy; 2005 May; 60(5):643-9. PubMed ID: 15813810
[TBL] [Abstract][Full Text] [Related]
5. Selective type IV phosphodiesterase inhibitors prevent IL-4-induced IgE production by human peripheral blood mononuclear cells.
Coqueret O; Boichot E; Lagente V
Clin Exp Allergy; 1997 Jul; 27(7):816-23. PubMed ID: 9249275
[TBL] [Abstract][Full Text] [Related]
6. Effect of anti-immunoglobulin E on nasal inflammation in patients with seasonal allergic rhinoconjunctivitis.
Bez C; Schubert R; Kopp M; Ersfeld Y; Rosewich M; Kuehr J; Kamin W; Berg AV; Wahu U; Zielen S
Clin Exp Allergy; 2004 Jul; 34(7):1079-85. PubMed ID: 15248853
[TBL] [Abstract][Full Text] [Related]
7. In vitro differentiation of human monocytes to macrophages: change of PDE profile and its relationship to suppression of tumour necrosis factor-alpha release by PDE inhibitors.
Gantner F; Kupferschmidt R; Schudt C; Wendel A; Hatzelmann A
Br J Pharmacol; 1997 May; 121(2):221-31. PubMed ID: 9154331
[TBL] [Abstract][Full Text] [Related]
8. [Seasonal variations of serum-IgE and potential impact on dose-calculation of omalizumab (rhuMab-E25, anti-IgE)].
Beeh KM; Beier J; Buhl R
Pneumologie; 2004 Aug; 58(8):546-51. PubMed ID: 15293167
[TBL] [Abstract][Full Text] [Related]
9. Identification, characterization, and functional role of phosphodiesterase type IV in cerebral vessels: effects of selective phosphodiesterase inhibitors.
Willette RN; Shiloh AO; Sauermelch CF; Sulpizio A; Michell MP; Cieslinski LB; Torphy TJ; Ohlstein EH
J Cereb Blood Flow Metab; 1997 Feb; 17(2):210-9. PubMed ID: 9040501
[TBL] [Abstract][Full Text] [Related]
10. Regulation of human skin mast cell histamine release by PDE inhibitors.
Eskandari N; Bastan R; Peachell PT
Allergol Immunopathol (Madr); 2015; 43(1):37-41. PubMed ID: 24231152
[TBL] [Abstract][Full Text] [Related]
11. The role of phosphodiesterase in mediating the effect of protein kinase C on cyclic AMP accumulation upon kappa-opioid receptor stimulation in the rat heart.
Bian JS; Zhang WM; Pei JM; Wong TM
J Pharmacol Exp Ther; 2000 Mar; 292(3):1065-70. PubMed ID: 10688624
[TBL] [Abstract][Full Text] [Related]
12. Immunoglobulin G4-antibodies to rBet v 1 and risk of sensitization and atopic disease in the child.
Kihlström A; Hedlin G; Pershagen G; Troye-Blomberg M; Härfast B; Lilja G
Clin Exp Allergy; 2005 Dec; 35(12):1542-9. PubMed ID: 16393319
[TBL] [Abstract][Full Text] [Related]
13. Seasonal increase in specific IgE in serum induced by natural Japanese cedar pollen exposure in asymptomatic and symptomatic sensitized individuals.
Kakinoki Y; Ohashi Y; Kato A; Tanaka A; Washio Y; Yamada K; Masamoto T; Nasako Y; Nakai Y; Nakai Y
Acta Otolaryngol Suppl; 1998; 538():152-5. PubMed ID: 9879415
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy decreases seasonal rise in serum-soluble CD23 in seasonal allergic rhinitis.
Ohashi Y; Nakai Y; Tanaka A; Kakinoki Y; Ohno Y; Masamoto T; Sakamoto H; Kato A; Washio Y; Hayashi M
Laryngoscope; 1998 May; 108(5):706-11. PubMed ID: 9591550
[TBL] [Abstract][Full Text] [Related]
15. Specific IgE serum concentration is associated with symptom severity in children with seasonal allergic rhinitis.
Rolinck-Werninghaus C; Keil T; Kopp M; Zielen S; Schauer U; von Berg A; Wahn U; Hamelmann E;
Allergy; 2008 Oct; 63(10):1339-44. PubMed ID: 18782113
[TBL] [Abstract][Full Text] [Related]
16. Seasonal non-allergic rhinitis (SNAR)--a new disease entity? A clinical and immunological comparison between SNAR, seasonal allergic rhinitis and persistent non-allergic rhinitis.
Wedbäck A; Enbom H; Eriksson NE; Movérare R; Malcus I
Rhinology; 2005 Jun; 43(2):86-92. PubMed ID: 16008061
[TBL] [Abstract][Full Text] [Related]
17. Immunochromatographic assay for measurement of total IgE in tears, nasal mucus, and saliva of patients with allergic rhinoconjunctivitis.
Mimura T; Usui T; Mori M; Aixinjueluo W; Funatsu H; Noma H; Amano S
J Asthma; 2010 Dec; 47(10):1153-60. PubMed ID: 20950135
[TBL] [Abstract][Full Text] [Related]
18. [Interleukin 4, total and allergen-specific immunoglobulin E antibodies in the blood of individuals with an atopic constitution].
Paranos S; Pravica V; Bonaci B; Stojković-Mostarica M
Srp Arh Celok Lek; 1998; 126(3-4):92-6. PubMed ID: 9863362
[TBL] [Abstract][Full Text] [Related]
19. Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma.
Kopp MV; Hamelmann E; Zielen S; Kamin W; Bergmann KC; Sieder C; Stenglein S; Seyfried S; Wahn U;
Clin Exp Allergy; 2009 Feb; 39(2):271-9. PubMed ID: 19016798
[TBL] [Abstract][Full Text] [Related]
20. Number of beta-receptors in rhinitic pollinic patients.
Gamboa PM; Sanz ML; de la Cuesta CG; García BE; Castillo JG; Oehling A
J Investig Allergol Clin Immunol; 1991 Apr; 1(2):113-21. PubMed ID: 1727009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
